During carcinogenesis, PKM2, an enzyme involved in the last and rate-limiting step of glycolysis, is converted to its dimeric form within cancer cells 9, which increases glucose uptake and facilitates the accumulation of glycolytic intermediates important for anabolic processes such as the synthesis of nucleic acids, amino acids, and lipids 6, 10, 11. Here, PKM is linked to cancer.